News

3 Reasons to Sell TNDM and 1 Stock to Buy Instead

Shareholders of Tandem Diabetes would probably like to forget the past six months even happened. The stock dropped 54.1% and now trades at $20.22. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

3 Reasons to Avoid HII and 1 Stock to Buy Instead

Huntington Ingalls’s stock price has taken a beating over the past six months, shedding 20.7% of its value and falling to $206.40 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.